statistiche ricercatore

Continente	#
NA - Nord America	677
EU - Europa	540
AS - Asia	525
SA - Sud America	64
Continente sconosciuto - Info sul continente non disponibili	22
AF - Africa	16
OC - Oceania	2
Totale	1.846

Nazione	#
US - Stati Uniti d'America	654
IT - Italia	319
SG - Singapore	158
CN - Cina	150
VN - Vietnam	63
DE - Germania	46
HK - Hong Kong	46
BR - Brasile	43
GB - Regno Unito	38
BD - Bangladesh	29
KR - Corea	29
SE - Svezia	25
NL - Olanda	21
FR - Francia	19
FI - Finlandia	18
RU - Federazione Russa	18
CA - Canada	15
ID - Indonesia	10
ZA - Sudafrica	10
IN - India	8
CO - Colombia	7
CZ - Repubblica Ceca	7
IQ - Iraq	7
MX - Messico	6
LT - Lituania	5
ES - Italia	4
JP - Giappone	4
AR - Argentina	3
CL - Cile	3
EC - Ecuador	3
IL - Israele	3
PK - Pakistan	3
PL - Polonia	3
SI - Slovenia	3
UZ - Uzbekistan	3
AL - Albania	2
AU - Australia	2
AZ - Azerbaigian	2
DZ - Algeria	2
IE - Irlanda	2
MA - Marocco	2
PY - Paraguay	2
UA - Ucraina	2
XK - ???statistics.table.value.countryCode.XK???	2
AT - Austria	1
BE - Belgio	1
BG - Bulgaria	1
BN - Brunei Darussalam	1
BO - Bolivia	1
CH - Svizzera	1
EG - Egitto	1
GR - Grecia	1
KG - Kirghizistan	1
LB - Libano	1
MD - Moldavia	1
MK - Macedonia	1
MN - Mongolia	1
MY - Malesia	1
NA - Namibia	1
NI - Nicaragua	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
RS - Serbia	1
SA - Arabia Saudita	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TR - Turchia	1
VE - Venezuela	1
Totale	1.826

Nome	#
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms	271
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis	271
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms	252
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis	248
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model	247
L’inibizione della migrazione di cellule CD14+ e CD34+ con un anticorpo anti-CD44 come nuovo approccio terapeutico per contrastare l’emopoiesi extramidollare in pazienti con mielofibrosi	226
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts	177
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis	123
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model	31
Totale	1.846

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	65	0	0	0	2	9	2	2	4	12	10	6	18
2022/2023	92	8	9	10	5	6	4	0	8	10	8	5	19
2023/2024	161	16	2	13	22	14	7	13	19	3	7	19	26
2024/2025	518	11	8	4	21	93	61	50	34	51	20	97	68
2025/2026	904	86	45	67	91	111	45	122	41	98	93	57	48
2026/2027	86	29	57	0	0	0	0	0	0	0	0	0	0
Totale													1.846